BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Eastern Standard Time
X-LIC-LOCATION:America/New_York
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:EST
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:EDT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2023 Annual Meeting by the American Academy of Neurology\n\nTi
 tle: Industry Therapeutic Update From Alexion: New Long-term Efficacy and
  Safety Analyses in Adult Patients With Anti-AChR Antibody-Positive gMG o
 n an FDA-Approved Treatment Option\n\nAccess URL: https://www.aan.com/msa
 /Public/Events/GetEventURL/15669\n\nLearn More About This Event: https://
 www.aan.com/msa/Public/Events/Details/15669
DTEND;TZID=Eastern Standard Time:20230426T124500
DTSTAMP:20260424T053423Z
DTSTART;TZID=Eastern Standard Time:20230426T114500
LOCATION:https://www.aan.com/msa/Public/Events/GetEventURL/15669
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update From Alexion: New Long-term Effic
 acy and Safety Analyses in Adult Patients With Anti-AChR Antibody-Positiv
 e gMG on an FDA-Approved Treatment Option
UID:ae2587ff-7ccb-435d-8cff-d6587bda42c0
END:VEVENT
END:VCALENDAR